These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38267800)

  • 1. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.
    Kurasawa S; Kato S; Ozeki T; Akiyama S; Ishimoto T; Mizuno M; Tsuboi N; Kato N; Kosugi T; Maruyama S;
    Clin Exp Nephrol; 2024 May; 28(5):431-439. PubMed ID: 38267800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
    Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV
    Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
    Cara-Fuentes G; Wei C; Segarra A; Ishimoto T; Rivard C; Johnson RJ; Reiser J; Garin EH
    Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.
    Spinale JM; Mariani LH; Kapoor S; Zhang J; Weyant R; Song PX; Wong HN; Troost JP; Gadegbeku CA; Gipson DS; Kretzler M; Nihalani D; Holzman LB;
    Kidney Int; 2015 Mar; 87(3):564-74. PubMed ID: 25354239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM; Ezzat DA; Doudar NA; Adel M
    Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
    Voznesenskaia TS; Sergeeva TV
    Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-like-4 and minimal change disease.
    Cara-Fuentes G; Segarra A; Silva-Sanchez C; Wang H; Lanaspa MA; Johnson RJ; Garin EH
    PLoS One; 2017; 12(4):e0176198. PubMed ID: 28441404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
    Li F; Zheng C; Zhong Y; Zeng C; Xu F; Yin R; Jiang Q; Zhou M; Liu Z
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1903-11. PubMed ID: 25318750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
    Minamikawa S; Nozu K; Maeta S; Yamamura T; Nakanishi K; Fujimura J; Horinouchi T; Nagano C; Sakakibara N; Nagase H; Shima H; Noda K; Ninchoji T; Kaito H; Iijima K
    Sci Rep; 2018 Nov; 8(1):17322. PubMed ID: 30470792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating suPAR as a biomarker of disease severity in children with proteinuric glomerulonephritis.
    Sołtysiak J; Zachwieja J; Benedyk A; Lewandowska-Stachowiak M; Nowicki M; Ostalska-Nowicka D
    Minerva Pediatr; 2019 Feb; 71(1):4-11. PubMed ID: 27070416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
    Ling C; Liu X; Shen Y; Chen Z; Fan J; Jiang Y; Meng Q
    Pediatr Nephrol; 2018 Jul; 33(7):1183-1187. PubMed ID: 29569191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis.
    An JN; Hyeon JS; Jung Y; Choi YW; Kim JH; Yang SH; Oh S; Kwon S; Lee SH; Cho JH; Park SH; Ha H; Kim DK; Lee JP; Hwang GS
    Sci Rep; 2019 Oct; 9(1):14707. PubMed ID: 31605028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of fractional excretion of magnesium with steroid responsiveness in children with nephrotic syndrome.
    Rumana J; Hanif M; Muinuddin G; Maruf-Ul-Quader M
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):830-6. PubMed ID: 24969196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.